Population analysis for the optimization of digoxin treatment in Japanese paediatric patients

Journal of Clinical Pharmacy and Therapeutics

Volumn 24, Issue 3, 1999, Pages 203-208

  Suematsu, Fumihiro ^a   Minemoto, M ^a   Yukawa, E ^b   Higuchi, S ^b  

^a KYUSHU KOSEI NENKIN HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC GLYCOSIDE; CREATININE; DIGOXIN; POTASSIUM SPARING DIURETIC AGENT; SPIRONOLACTONE;

AGE; ARTICLE; BODY WEIGHT; CHILD; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG CLEARANCE; FEMALE; GENDER; HUMAN; INFANT; JAPAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; PEDIATRICS; POPULATION; PREMATURITY;

AGE FACTORS; BODY WEIGHT; CARDIOTONIC AGENTS; CHILD; CHILD, PRESCHOOL; DIGOXIN; DRUG INTERACTIONS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INFANT; INFANT, NEWBORN; MALE; SEX FACTORS; SPIRONOLACTONE;

EID: 0032816910     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.1999.00221.x     Document Type: Article

References (24)

1. Wagner JG. (1974) Appraisal of digoxin bioavailability and pharmacokinetics in relation to cardiac therapy. American Heart Journal, 88, 133-138.
2. Dungan Wt, Doherty JE, Harvey C, Char F, Dalrymple GW. (1972) Tritiated digoxin XVII, Studies in infants and children. Circulation, 46, 983-988.
3. Wettell G. (1977) Distribution and elimination of digoxin in infants. European Journal of Clinical Phamacology, 11, 329-335.
4. Wettrel G, Anderson KE, Bertler A, Lundstrom NR. (1974) Concentration of digoxin in plasma and urine in neonates, infants and children with heart disease. Acta Paediatrica Scandinavica, 63, 705-710.
5. Wettrel G, Anderson KE. (1975) Absorption of digoxin in infants. European Journal of Clinical Pharmacology, 9, 49-55.
6. Larsen A, Storstein L. (1983) Digoxin kinetics and renal excretion in children. Clinical Pharmacology and Therapeutics, 33, 717-726.
7. Halkin H, Radornsky M, Millman P, Almog S, Blieden L, Boichis H. (1978) Steady state serum concentrations and renal clearance of digoxin in neonates, infants and children. European Journal of Clinical Pharmacology, 13, 113-117.
8. Hori R, Miyazaki K, Mizugaki M, et al. (1994) Estimation of population pharmacokinetic parameters in the Japanese. 1. Digoxin. Japanese Journal of TDM, 19, 7-17.
9. Yukawa E, Mine H, Higuchi S, Aoyama T, (1992) Digoxin population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens. Journal of Pharmacy and Pharmacology, 44, 761-765.
10. Yukawa E, Honda T, Ohdo S, Higuchi S, Aoyama T. (1997) Population-based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis; an update. Journal of Clinical Pharmacology, 37, 92-100.
11. Nyberg L, Wettrell G. (1980) Pharmacokinetics and dosage of digoxin in neonates and infants. European Journal of Clinical Pharmacology, 18, 69-74.
12. Wettrel G, Anderson KE. (1977) Clinical pharmacokinetics of digoxin in infants. Clinical Pharmacokinetics, 2, 17-31.
13. Nyberg L, Wettrell G. (1978) Digoxin dosage schedules for neonates and infants based on pharmacokinetic considerations. Clinical Pharmacokinetics, 3, 453-461.
14. Pinsky WW, Jacobsen JR, Gillette PC, et al. (1976) Serum digoxin levels in premature infants. Pediatric Research, 10, 333.
15. Fenster PE, Hager WD, Goodman MM. (1984) Digoxinquinidine - spironolactone interaction. Clinical Pharmacology and Therapeutics, 36, 70-73.
16. Lichey J, Schroder R, Rietbrock N. (1977) The effect of oral spironolactone and intravenous canrenoate-K on the digoxin radioimmunoassay. International Journal of Clinical Pharmacology and Biopharmacy, 15, 557-559.
17. Fokaridis GN. (1990) Influence of spironolactone and its metabolite canrenone on serum digoxin assays. Therapeutic Drug Monitoring, 12, 82-84.
18. Hori R, Okamura N, Aiba T, Tanigawara Y. (1993) Role of P-glycoprotein in renal tubular secretion of digoxin in the isolated perfused rat kidney. Journal of Pharmacology and Experimental Therapeutics, 266, 1620-1625.
19. I). Journal of Pharmacology and Experimental Therapeutics, 263, 840-845.
20. Sheiner LB, Rosenberg B, Marathe VV. (1977) Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. Journal of Pharmacokinetics and Biopharmaceutics, 5, 445-479.
21. Naafs MAB, van der Hoek C, van Duin S, Koorevaar G, Schopman W, Silberbusch J. (1985) Decreased renal clearance of digoxin in chronic congestive heart failure. European Journal of Clinical Pharmacology, 29, 249-252.
22. Valdes R Jr, Graves SW, Brown BA, Landt M. (1983) Endogenous substance in newborn infants causing false positive digoxin measurements. Journal of Pediatrics, 102, 947-950.
23. Morris RP, David WS, Beryl EJ, Michael FW. (1983) Seven different immunoassay kits compared with respect to interference by a digoxin-like substance in serum from premature and full-term infants. Clinical Chemistry, 29, 1972-1974.
24. Ishii T, Ohisa N, Karino A, Ishii K, Munakata Y, Sasaki A. (1996) Fundamental study of CEDIA digoxin plus assay and CEDIA theophylline assay on the Hitachi-7070 analyzer. Journal of Clinical Laboratory Instrument and Reagent, 19, 171-177.